# Evaluation of the Pathobiology of CALR-mutated MPN Cells

> **NCT06480591** · — · RECRUITING · sponsor: **Wake Forest University Health Sciences** · enrollment: 35 (estimated)

## Conditions studied

- Myeloproliferative Neoplasm

## Interventions

- **OTHER:** Blood Draw

## Key facts

- **NCT ID:** NCT06480591
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-21
- **Primary completion:** 2026-07
- **Final completion:** 2026-09
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06480591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06480591, "Evaluation of the Pathobiology of CALR-mutated MPN Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06480591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*